VINEETLAB

Vineet Laboratories Share Price

₹49.47 -0.65 (-1.3%)

21 Nov, 2024 14:47

SIP TrendupStart SIP in VINEETLAB

Start SIP

Performance

  • Low
  • ₹49
  • High
  • ₹51
  • 52 Week Low
  • ₹47
  • 52 Week High
  • ₹89
  • Open Price₹50
  • Previous Close₹50
  • Volume10,656

Investment Returns

  • Over 1 Month -16.25%
  • Over 3 Month -18.84%
  • Over 6 Month -7.53%
  • Over 1 Year -27.94%
SIP Lightning

Smart Investing Starts Here Start SIP with Vineet Laboratories for Steady Growth!

Invest Now

Vineet Laboratories Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • -11.1
  • PEG Ratio
  • 0.1
  • Market Cap Cr
  • 46
  • P/B Ratio
  • 1.3
  • Average True Range
  • 2.76
  • EPS
  • 0
  • Dividend Yield
  • 0
  • MACD Signal
  • -0.78
  • RSI
  • 30.59
  • MFI
  • 32.23

Vineet Laboratories Financials

Vineet Laboratories Technicals

EMA & SMA

Current Price
₹49.47
-0.65 (-1.3%)
pointer
  • stock-down_img
  • Bullish Moving Average 0
  • stock-up_img
  • Bearish Moving Average 16
  • 20 Day
  • ₹55.08
  • 50 Day
  • ₹56.86
  • 100 Day
  • ₹57.96
  • 200 Day
  • ₹58.48

Resistance and Support

50.97 Pivot Speed
  • R3 54.45
  • R2 53.57
  • R1 51.85
  • S1 49.25
  • S2 48.37
  • S3 46.65

What's your outlook on Vineet Laboratories?

You can only vote for once

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Vineet Laboratories has an operating revenue of Rs. 112.51 Cr. on a trailing 12-month basis. An annual revenue de-growth of -29% needs improvement, Pre-tax margin of 0% needs improvement, ROE of 2% is fair but needs improvement. The company has a reasonable debt to equity of 11%, which signals a healthy balance sheet. From an O'Neil Methodology perspective, the stock has an EPS Rank of 7 which is a POOR score indicating inconsistency in earnings, a RS Rating of 15 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at C+ which is evident from recent supply seen, Group Rank of 39 indicates it belongs to a strong industry group of Medical-Diversified and a Master Score of D is close to being the worst. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment. Please note that this is a thinly traded stock.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Vineet Laboratories Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2024-11-13 Quarterly Results
2024-08-13 Quarterly Results
2024-05-29 Audited Results
2024-02-12 Quarterly Results
2023-11-10 Quarterly Results
Date Purpose Remarks
2022-09-20 FINAL Rs.1.00 per share(10%)Final Dividend

Vineet Laboratories F&O

Vineet Laboratories Shareholding Pattern

36.07%
0%
60.65%
3.28%

About Vineet Laboratories

  • NSE Symbol
  • VINEETLAB
  • BSE Symbol
  • 543298
  • Managing Director
  • Mr. Gaddam Venkata Ramana
  • ISIN
  • INE505Y01010

Similar Stocks to Vineet Laboratories

Vineet Laboratories FAQs

Vineet Laboratories share price is ₹49 As on 21 November, 2024 | 14:33

The Market Cap of Vineet Laboratories is ₹45.6 Cr As on 21 November, 2024 | 14:33

The P/E ratio of Vineet Laboratories is -11.1 As on 21 November, 2024 | 14:33

The PB ratio of Vineet Laboratories is 1.3 As on 21 November, 2024 | 14:33

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23